EUVIMEDEUVIMED entdecken
Crossref

1205-OR: Tissue-Specific Mitochondrial Adaptations Parallel Metabolic Improvements after Bariatric Surgery

KALLIOPI PAFILI, KÁLMÁN B. BÓDIS, CHRISTIAN BINSCH, LUCIA MASTROTOTARO, BEDAIR DEWIDAR, GERONIMO HEILMANN, JENNIFER PÜTZER, SOFIYA GANCHEVA, ASLIHAN YAVAS, IRENE ESPOSITO, MATTHIAS SCHLENSAK, FRANK A. GRANDERATH und 3 weitere

Diabetes · 06.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-1205-or ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 06.06.2026. Verfasst von KALLIOPI PAFILI und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Humans with obesity-related insulin resistance (IR) and metabolic dysfunction-associated steatotic liver disease (MASLD) show different mitochondrial alterations. While oxidative phosphorylation (OXPHOS) can be increased in liver, it may be decreased in visceral (VAT), but neither in subcutaneous adipose tissue (SAT) nor skeletal muscle (SM). However, it remains unclear how weight loss affects tissue-specific OXPHOS. We hypothesized that bariatric surgery would induce mitochondrial adaptation mainly in VAT in parallel to improved IR and hepatic lipid content (HLC).

Methods

Within the prospective BARIA-DDZ study, participants underwent bariatric surgery (baseline, BL) and elective follow-up (FU) surgery (interval 29±18 months). Whole-body insulin sensitivity (M-value) was measured by hyperinsulinemic-euglycemic clamps, HLC by histology and adipose IR by the Adipo-IR index. During surgery, VAT, SAT, liver and SM biopsies were obtained to assess maximal fatty acid oxidation+complex (C)I+II-linked OXPHOS capacity ([CI+II]P) and substrate control ratio (SCR) by high-resolution respirometry and protein expression of CI-CV by Western blotting.

Results

At BL, 16 individuals (42±2 years, 75% female, BMI 52±2 kg/m²) featured IR (M-value 3.4±0.5 mg*kg-1*min-1, Adipo-IR 8.1±1.4 mmol*l-1*pmol*l-1) and hepatic steatosis (25.0±6.6%). At FU, they showed 33% weight loss, 62% higher M-value, 59% lower Adipo-IR, and 89% less HLC (all p<0.05). [CI+II]P increased by 103% in VAT and 38% in SAT, paralleled by a 110% and 54% rise in CV content, respectively (all p<0.05); CI-CIV content remained unchanged. In SM and liver [CI+II]P and CI-CV content were unchanged. SCR improved only in VAT (13%) and liver (12%; both p<0.05).

Conclusion

Surgical weight loss improves (i) mitochondrial respiration in VAT and to less extent in SAT, partly via increased mitochondrial biogenesis, and (ii) mitochondrial efficiency in VAT and liver, suggesting a beneficial visceral adipose-liver crosstalk for IR and MASLD. Disclosure K. Pafili: None. K.B. Bódis: Other - travel support; Ended; Sanofi. Other - lecture honoraria; Ended; Pfizer Inc. C. Binsch: None. L. Mastrototaro: None. B. Dewidar: None. G. Heilmann: None. J. Pützer: None. S. Gancheva: None. A. Yavas: None. I. Esposito: None. M. Schlensak: None. F.A. Granderath: None. P. Schrauwen: Consultant; Current; AstraZeneca. Research Support; Ended; Pfizer Inc., MedImmune. S. Kahl: None. M. Roden: Advisory Panel; Current; AstraZeneca, Boehringer Ingelheim International GmbH, Lilly, Madrigal Pharmaceuticals, Inc., Novo Nordisk, Sanofi, Echosens. Funding The research of KP is supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation): Project number 493659010 in the context of the Clinician Scientist Program (FUTURE-4-CSPMM) and by grants from the German Diabetes Research (DZD) foundation and the Heinrich-Heine-University Düsseldorf.

Zitieren

APA

PAFILI, K., BÓDIS, K. B., BINSCH, C., MASTROTOTARO, L., DEWIDAR, B., HEILMANN, G., PÜTZER, J., GANCHEVA, S., YAVAS, A., ESPOSITO, I., SCHLENSAK, M., GRANDERATH, F. A., SCHRAUWEN, P., KAHL, S., & RODEN, M. (2026). 1205-OR: Tissue-Specific Mitochondrial Adaptations Parallel Metabolic Improvements after Bariatric Surgery. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-1205-or

Vancouver

PAFILI K, BÓDIS KB, BINSCH C, MASTROTOTARO L, DEWIDAR B, HEILMANN G, et al. 1205-OR: Tissue-Specific Mitochondrial Adaptations Parallel Metabolic Improvements after Bariatric Surgery. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-1205-or

BibTeX
@article{PAFILI2026,
  author = {PAFILI, KALLIOPI and BÓDIS, KÁLMÁN B. and BINSCH, CHRISTIAN and MASTROTOTARO, LUCIA and DEWIDAR, BEDAIR and HEILMANN, GERONIMO and PÜTZER, JENNIFER and GANCHEVA, SOFIYA and YAVAS, ASLIHAN and ESPOSITO, IRENE and SCHLENSAK, MATTHIAS and GRANDERATH, FRANK A. and SCHRAUWEN, PATRICK and KAHL, SABINE and RODEN, MICHAEL},
  title = {1205-OR: Tissue-Specific Mitochondrial Adaptations Parallel Metabolic Improvements after Bariatric Surgery},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-1205-or}
}
Kostenlos starten →